Rivian keeps promise on making a profit, but here’s why the stock is falling
Read more at MarketWatch
-
Profits, Not D.E.I., Are Why Companies Exist
An awkward truth has become evident in the first days of the Trump administration, as many firms mute their commitments to diversity and sustainability.The New York Times - 6h -
Block shares fall on profit, revenue miss
Block, formerly known as Square, got off to a sluggish start on Wall Street this year after underperforming the Nasdaq in 2024.CNBC - 20h -
Why 'Severance' would fall flat with the American workforce
While there’s no polling data asking about whether we’d be willing to become “severed,” don’t expect Americans to clamor for it any time soon.The Hill - 3h -
Why the Price of Gold Keeps Going Up
The precious metal, considered a haven asset, is usually sought out by investors during times of turmoil.The New York Times - 4h -
President Trump is losing the stock market war to the rest of the world so far. Here's where investors are taking advantage
Emerging market stocks, China and European stocks are beating U.S. indexes since the inauguration of Donald Trump.CNBC - 5h -
Crypto exchange Bybit suffers $1.4 billion hack. Here’s why it’s troubling for the industry.
The hack of Bybit is the latest incident in which the crypto industry has been targeted.MarketWatch - 1h -
Men: Kansas keeps sliding
Never has Kansas been worse than a 4-seed under Bill Self -- until this season (potentially). Is this a blip in the Jayhawks' decades of consistently high-quality seasons?ESPN - 4h -
Next Likely Chancellor Promises a Tougher Germany
Friedrich Merz, whose conservative party is ahead in polls before Sunday’s election, sees an “epochal rupture” with a United States that is more aligned with Russia.The New York Times - 1d -
Comparing Trump's executive orders with Project 2025 promises
According to a CBS News analysis, President Trump has signed 73 executive orders so far, targeting everything from the border to the environment and federal spending. Many online users have pointed ...CBS News - 19h
More from MarketWatch
-
Warren Buffett’s growing cash pile and 3 other things investors want to hear about in Berkshire’s investor letter
Investors are awaiting Berkshire Hathaway Chairman Warren Buffett’s annual investor letter, in which he typically expounds on Berkshire’s performance along with anecdotes and vignettes about ...MarketWatch - 41m -
UnitedHealth Medicare Advantage bombshell exposes $83 billion in government waste
Will Musk and Trump dare to take it on?MarketWatch - 41m -
Your retirement savings are at risk in an insane stock market
Fund managers admit they’re buying overvalued stocks.MarketWatch - 53m -
Celsius wants to sell more energy drinks to women. Wall Street likes the move.
Celsius shares are up more than 30% after its quarterly results topped estimates and it announced plans to buy drink maker Alani Nu.MarketWatch - 1h -
Walmart’s stock continues to drop despite ‘near-term buying opportunity’
Walmart Inc.’s stock deepened its losses on Friday after a brutal selloff in the previous session, as investors brushed aside positive comments from analysts.MarketWatch - 1h
More in Business
-
Germany’s Merz says Europe can no longer rely on US protection
Frontrunner for chancellor suggests possible nuclear co-operation with the UK and FranceFinancial Times - 15m -
Hackers steal $1.5bn from crypto exchange Bybit in biggest-ever heist
Theft deals blow to an industry that has been reinvigorated by Donald Trump’s re-electionFinancial Times - 26m -
Steve Cohen says tariffs and DOGE's cuts are negative for economy, market correction could be soon
The CEO of hedge fund Point72 turned bearish for the first time in a while due to punitive tariffs, immigration crackdown and federal spending cuts.CNBC - 32m -
Did the Covid-19 Pandemic Change How You Travel? Let Us Know.
The pandemic was declared in March 2020, shutting down travel for months. How did the lockdowns, and then the surge in demand, change the way you travel?The New York Times - 36m -
Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says
The FDA's decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the injections over the next few months.CNBC - 37m